Can you summarize the interventions for biliary tract disease for a general surgery exam?

Biliary Tract Interventions for General Surgery Exam

Diagnostic Interventions

Initial Imaging and Assessment

• Transabdominal ultrasound is the first-line imaging modality for suspected biliary pathology, with sensitivity 32-100% and specificity 71-97% for detecting bile duct dilatation and obstruction 1
• MRCP provides detailed visualization of biliary anatomy and is essential before surgical planning, particularly for perihilar/distal cholangiocarcinoma and complex cases like Mirizzi syndrome 2, 3
• CT chest/abdomen/pelvis with multiphase liver imaging is required for staging biliary tract cancers and detecting metastases 2

Endoscopic Diagnostic Procedures

• ERCP with biliary brushings or biopsy has limited sensitivity for malignant strictures; combining both techniques only modestly increases diagnostic yield 2
• EUS allows assessment of locoregional extension of perihilar/distal cholangiocarcinoma and gallbladder cancer, identifies biliary obstruction location, and enables tissue acquisition from primary tumors or nodal metastases 2
• Cholangioscopy with direct visualization and optical-guided biopsies improves diagnostic accuracy for indeterminate biliary strictures 4
• PET-CT may identify nodal metastases, distant metastases, and disease recurrence when available 2

Therapeutic Interventions for Biliary Obstruction

First-Line: Endoscopic Approach

• ERCP with biliary sphincterotomy and removable plastic stent placement is the first-line treatment for dilated common bile duct with choledocholithiasis and malignant obstruction 5, 1
• Complete stone extraction should be performed during initial ERCP when possible; ERCP successfully clears CBD stones in 80-95% of cases 5, 1
• Standard biliary sphincterotomy with balloon/basket extraction is used for most stones 5
• For large stones, add endoscopic papillary balloon dilation (EPBD) and mechanical lithotripsy 5
• If complete extraction is not possible, temporary stenting ensures adequate drainage with definitive treatment within 4-6 weeks 5, 3

Second-Line: Percutaneous Approach

• Percutaneous transhepatic biliary drainage (PTBD) is the second-line option when ERCP fails or is not feasible, though it carries 2.5% bleeding complication rate 3, 1
• PTBD is contraindicated in patients with uncorrected coagulopathy (INR >2.0 or platelet count <60K) or moderate-to-massive ascites due to bleeding risk and ascitic fluid leakage 5, 3, 1
• Rendezvous technique combining percutaneous and endoscopic approaches can be used for difficult cases 3
• High bile duct obstruction is usually best managed percutaneously to target specific ducts and avoid enteric contamination 6

Alternative: EUS-Guided Biliary Drainage

• EUS-guided biliary drainage (EUS-BD) is an emerging alternative to PTBD after failed ERCP 7
• EUS-guided hepaticogastrostomy versus choledochoduodenostomy can be used for distal malignant biliary obstruction 7
• EUS-directed transgastric ERCP (EDGE) is an option for patients with Roux-en-Y gastric bypass anatomy 7

Therapeutic Interventions for Specific Conditions

Choledocholithiasis Management

• For patients with coagulopathy, consider EPBD without prior sphincterotomy using an 8mm diameter balloon 5
• Cholecystectomy should be performed within 2-4 weeks of successful ERCP in patients with intact gallbladder to prevent recurrence 5
• Laparoscopic bile duct exploration (LBDE) is an equally effective alternative to perioperative ERCP, with choice based on local expertise 5
• For high surgical risk patients, biliary sphincterotomy and endoscopic duct clearance alone (without cholecystectomy) is acceptable 5

Acute Cholangitis

• Urgent biliary decompression with ERCP stone extraction and/or stenting is mandatory for patients with acute cholangitis or septic shock who fail antibiotic therapy 5, 3, 1
• Never delay biliary decompression in this setting 1

Mirizzi Syndrome

• ERCP with biliary sphincterotomy and removable plastic stent is the initial therapeutic procedure for dilated intrahepatic bile ducts from biliary obstruction 3
• Do not perform surgery during the acute inflammatory phase; allow minimum 3 weeks for inflammation to subside after biliary drainage 3
• MRCP should complement initial imaging for exact visualization and classification before definitive surgical planning 3

Acute Cholecystitis (Non-Surgical Candidates)

• EUS-guided gallbladder drainage (EUS-GBD) versus percutaneous gallbladder drainage are options for patients who are not cholecystectomy candidates 7
• Endoscopic transpapillary transcystic gallbladder drainage is another alternative 7

Biliary Stenting and Stone Management

Stent Placement

• Internal/external biliary drainage with removable plastic stents is standard for temporary drainage 5, 3
• Monitor for signs of stent occlusion (recurrent abdominal pain, jaundice, cholangitis) and schedule definitive treatment within 4-6 weeks 5
• Cholangioplasty and biliary stenting can be performed percutaneously for benign and malignant strictures 8

Stone Extraction

• Biliary stone extraction can be performed percutaneously using baskets, snares, and lithotripsy probes 4, 8
• Cholangioscopy-guided lithotripsy is useful for difficult stones 4

Tissue Acquisition for Biliary Tract Cancer

Biopsy Techniques

• Core biopsy should be confirmed before any non-surgical treatment for biliary tract cancer 2
• For patients with localised tumors amenable to curative surgery, biopsy should not be routinely undertaken 2
• For biliary obstruction due to perihilar/distal cholangiocarcinoma without extraductal metastasis, PTC- or ERCP-guided biopsies are preferred over biliary brush cytology whenever possible to ensure adequate tissue for diagnostic pathology and molecular profiling 2
• EUS-guided FNA or FNB may obtain biopsies from the primary tumor or nodal metastases depending on location 2
• Endobiliary biopsy techniques and cholangioscopy with optical-guided biopsies improve diagnostic yield 4, 8

Critical Pitfalls to Avoid

• ERCP carries 4-5.2% risk of major complications and 0.4% mortality risk, which must be weighed against benefits 1
• Endoscopic sphincterotomy carries significantly higher complication rates (up to 19%) in elderly patients 3
• Avoid using EUS for initial evaluation of jaundice—it has limited field of view and 6.3% complication rate 1
• Avoid percutaneous approaches in patients with moderate-to-massive ascites 5, 3
• For Mirizzi syndrome, never operate during acute inflammation; wait minimum 3 weeks after drainage 3